Biotricity, Inc.
BTCY
$0.25
$0.00-1.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.02M | -4.53M | -5.40M | -8.42M | -10.67M |
| Total Depreciation and Amortization | 759.10K | 744.80K | 717.70K | 717.70K | 674.10K |
| Total Amortization of Deferred Charges | 705.30K | 810.90K | 948.70K | 1.94M | 2.37M |
| Total Other Non-Cash Items | 1.75M | 1.63M | 1.65M | 2.42M | 924.90K |
| Change in Net Operating Assets | -293.80K | 896.60K | 819.40K | 962.20K | 3.55M |
| Cash from Operations | -1.10M | -446.70K | -1.26M | -2.38M | -3.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2.04M | 1.95M | 2.28M | 1.84M | 2.20M |
| Total Debt Repaid | -1.00M | -1.21M | -1.18M | -1.73M | -1.41M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 125.20K | 125.20K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | 0.00 | 0.00 | 420.00K | 1.73M | 2.66M |
| Repurchase of Preferred Stock | -200.00K | -200.00K | -- | -- | -- |
| Total Dividends Paid | -24.10K | -24.00K | -23.90K | -30.00K | -23.90K |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 814.30K | 518.00K | 1.50M | 1.93M | 3.55M |
| Foreign Exchange rate Adjustments | 31.30K | -90.00K | -100.80K | -123.90K | -136.90K |
| Miscellaneous Cash Flow Adjustments | -- | 153.80K | 153.80K | 153.80K | 153.80K |
| Net Change in Cash | -253.30K | 135.10K | 290.40K | -421.00K | 424.50K |